ACOG Committee Opinion: Use of progesterone to reduce preterm birth. American College of Obstetricians and Gynecologists. Noviembre 2003: Number 291.
Adams, MM, Elam-Evans, LD, Wilson HG, Gilbertz DA. Rates of and factors associated with recurrence of preterm delivery.
JAMA.
2000;283:1591-1596.
Ananth, CV, Getahun D, Peltier MR, Salihu HM, Vintzileos AM. Recurrence of spontaneous versus medically indicated preterm birth.
Am J Obstet Gynecol.
2006;195:643-650.
Berghella V, Klebanoff M, McPherson C, et al. National Institute for Child Health and Development Maternal Fetal Medicine Units Network. Sexual intercourse association with asymptomatic bacterial vaginosis and trichomonas vaginalis treatment in relationship to preterm birth.
Am J Obstet Gynecol.
2002;187:1277-1282.
Bloom SL, Yost NP, McIntire DD, Leveno KJ, Recurrence of preterm birth in singleton and twin pregnancies. Obstet Gynecol. 2001;98:379-385.
Buchmayer SM, Sparen P, and Cnattingius S. Previous pregnancy loss: risks related to severity of preterm delivery.
Am J Obstet Gynecol.
2004:191:1225-1231.
Conde-Agudelo A, Rosas-Bermudez A, Kafury-Goeta C. Birth spacing and risk of adverse perinatal outcomes.
JAMA.
2006;295:1809-1823.
Crowther CA, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease.
The Cochrane Database of Systematic Reviews.
2006;(4). Last updateed: Abril 22, 2003.
da Fonseca EB, Bittar RE, Carvalho MH, et al. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study.
Am J Obstet Gynecol.
188:419-424.
Dodd JM, Crowther CA, Cincotta R, Flenady V, Robinson JS. Progesterone supplementation for preventing preterm birth: a systematic review and meta-analysis.
Acta Obstet Gynecol Scand.
2005;84:526-533.
Dodd JM, Flenady V, Cincotta R, Crowther CA. Prenatal administration of progesterone for preventing preterm birth.
Cochrane Database of Systematic Reviews.
2006;CD004947.
Drakeley AJ, Roberts D, Alfirevic Z. Cervical stitch (cerclage) for preventing pregnancy loss in women.
The Cochrane Database of Systematic Reviews.
2006(4). Last update: September 7, 2002.
Hauth JC, Gilstrap LC III, Brekken AL, Hauth JM. The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population.
Am J Obstet Gynecol.
1983;146:187-190.
Iams JD, Goldenberg RL, Meis PJ, et al. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network.
N Engl J Med.
1996;334:567-572.
Johnson JWC, Austin KL, Jones GS, Davis GH, King TM. Efficacy of 17 alpha-hydroxy-progesterone caproate in the prevention of premature labor.
N Engl J Med.
1975;293:675-680.
Kramer MS, Demissie K, Yang H, Platt RW, Sauve R, Liston R. The contribution of mild and moderate preterm birth to infant mortality. Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System.
JAMA.
2000;284:843-849.
Mackenzie R, Walker M, Armson A, Hannah ME. Progesterone for the prevention of preterm birth among women at increased risk: A systematic review and meta-analysis of randomized controlled trials.
Am Jo Obst and Gyn.
2006;194:1234-1242.
McDonald H, Brocklehurst P, Parsons J. Antibiotics for treating bacterial vaginosis in pregnancy.
The Cochrane Database of Systematic Reviews.
2006(4). Date update: Octubre 27, 2004.
Meis PJ, Goldenberg RL, Mercer BM, et al. Preterm prediction study: is socioeconomic status a risk factor for bacterial vaginosis in black or in white women?
Am J Perinatology.
2000;17:41-45.
Meis PJ, Klebanoff M, Dombrowski MP, et al. Does Progesterone treatment influence risk factors for recurrent preterm delivery?
Obstet Gynecol.
2005;106:557-561.
Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.
New Eng J Med.
2003;348:2379-2385.
Mercer BM, Goldenberg RL, Das A, et al. The preterm prediction study: a clinical risk assessment system.
Am J Obstet Gynecol.
1996;174:1885-1893, discussion 1893-1895.
Mercer BM, Goldenberg RL, Das A, et al. The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.
Am J Obstet Gynecol.
1999;181:1216-1221.
Ness A, Dias T, Damus K, Burd I and Berghella V. Impact of the recent randomized trials on the use of progesterone to prevent preterm birth: a 2005 follow-up survey.
Am J Obstet Gynecol.
2006;195:1174-1179.
Newton ER. Preterm labor. Disponible en: http://www.emedicine.com/med/topic3245.htm. Accedido septiembre 27, 2005.
Premature birth. Mayo Foundation for Medical Education and Research. Disponible en: http://www.mayoclinic.com/invoke.cfm?objectid=DB81ABF4-378D-453B-AFD7BF32AD6F01E7&dsection=1. Accedido septiembre 23, 2005.
Preterm labor.March of Dimes. Disponible en: http://www.marchofdimes.com/pnhec/188_1080.asp. Accedido septiembre 22, 2005.
Preterm labor. University of Michigan Health System. Disponible en: http://www.med.umich.edu/1libr/wha/wha_ptl_crs.htm. Accedido septiembre 23, 2005.
Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.
The Cochrane Database of Systematic Reviews.
2006;(4). Last update: Mayo 15.2006.
Sanchez-Ramos L, Kaunitz AM, Delke I. Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials.
Obstet Gynecol.
2005;105:273-279.
Sosa C, Althabe F, Belizán J, Bergel E. Bed rest in singleton pregnancies for preventing preterm birth.
The Cochrane Database of Systematic Reviews.
2006;(4). Last update: Octubre 1, 2003.
Surkan PM, Stephansson O, Dickman PW, Cnattingius S. Previous preterm and small-for-gestational-age births and the subsequent risk of stillbirth. New Eng J Med. 2004;350:777-785.
Thangaratinam S, Coomarasamy A. Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials.
Obstet Gynecol.
105:1483-1484.
Treating preterm labor. March of Dimes. Disponible en: http://www.marchofdimes.com/prematurity/13454_13468.asp. Accedido septiembre 23, 2005.
Weismiller DG. Preterm labor.
American Family Physician.
February 1, 1999. American Family Physician website. Disponible en: http://www.aafp.org/afp/990201ap/593.html. Accedido septiembre 26, 2005.
Yemini M, Borenstein R, Dreasen E, et al. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate.
Am J Obstet Gynecol.
1985;151:574-577.
Zhu BP, Haines KM, Le T, et al. Effect of the interval between pregnancies on perinatal outcomes among white and black women.
Am J Obstet Gynecol.
2001;185:1403-1410.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.